Atyr PharmaATYR
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 47 institutions reported holding Atyr Pharma Inc. (ATYR) in their 13F filings, down 9 from Q1 2024. 6 opened new positions and 17 sold out. The largest holders were Federated Hermes, Inc. ($22.9M), FMR LLC ($16.1M) and Logos Global Management LP ($4.7M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Atyr Pharma Inc.
- CUSIP
- 002120202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.1M |
| Exits | 17 | $4.4M |
All 13F filers, Q1 2024 → Q2 2024: 8,907,705 shares bought and 2,619,325 shares sold, net +6,288,380 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Federated Hermes, Inc. | 0.05% | Add +44.2% | 14,666,600 | $22.9M |
| FMR LLC | 0.00% | Add +16.0% | 10,351,641 | $16.1M |
| Logos Global Management LP | 0.54% | Reduce -3.2% | 3,000,000 | $4.7M |
| Vanguard Group Inc. | 0.00% | No change | 2,652,157 | $4.1M |
| Tikvah Management LLC | 1.26% | No change | 2,460,833 | $3.8M |
| Checkpoint Capital L.P. | 1.83% | Add +34.6% | 1,946,477 | $3.0M |
| Alyeska Investment Group, L.P. | 0.02% | Add +24.1% | 1,867,633 | $2.9M |
| Citadel Advisors | 0.00% | Reduce -3.0% | 1,845,262 | $2.9M |
| Woodline Partners LP | 0.03% | Add +0.1% | 1,683,162 | $2.6M |
| BlackRock Inc. | 0.00% | Add +2.0% | 1,392,074 | $2.2M |
| Renaissance Technologies | 0.00% | Add +1.6% | 1,293,814 | $2.0M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 1,000,000 | $1.6M |
| Ghost Tree Capital, LLC | 0.43% | Add +33.3% | 800,000 | $1.2M |
| Tang Capital Management LLC | 0.11% | Add +42.5% | 671,134 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +11.3% | 662,684 | $1.0M |
| Gsa Capital Partners LLP | 0.04% | Add +43.9% | 322,460 | $503K |
| Superstring Capital Management LP | 0.62% | New | 313,028 | $488K |
| State Street Corp. | 0.00% | Add +0.9% | 168,308 | $263K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -26.0% | 145,524 | $227K |
| Northern Trust Corp. | 0.00% | Add +19.4% | 118,456 | $185K |
| Bank of America Corp. | 0.00% | Reduce -25.1% | 117,037 | $183K |
| Millennium Management | 0.00% | Add +70.3% | 106,432 | $166K |
| Two Sigma Advisers, LP | 0.00% | Reduce -32.7% | 95,850 | $150K |
| Main Street Financial Solutions, LLC | 0.01% | Add +96.5% | 67,725 | $106K |
| American Century Companies Inc. | 0.00% | Add +11.9% | 60,487 | $94K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +89.8% | 38,900 | $61K |
| Farther Finance Advisors, LLC | 0.00% | Add +0.3% | 30,423 | $47K |
| Sanctuary Advisors, LLC | 0.00% | — | 29,207 | $46K |
| Jane Street Group, LLC | 0.00% | Reduce -54.2% | 28,456 | $44K |
| Virtu Financial LLC | 0.00% | New | 27,966 | $44K |
| D.A. Davidson & Co. | 0.00% | Add +5.7% | 27,850 | $43K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +336.2% | 27,338 | $43K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 26,689 | $42K |
| JPMorgan Chase & Co. | 0.00% | Reduce -38.9% | 20,686 | $32K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +40.5% | 16,485 | $26K |
| Royal Bank of Canada | 0.00% | Reduce -10.8% | 13,850 | $22K |
| Verition Fund Management LLC | 0.00% | New | 12,675 | $20K |
| Alterna Wealth Management, Inc. | 0.01% | No change | 10,000 | $16K |
| Wells Fargo & Company | 0.00% | Reduce -21.6% | 1,500 | $2K |
| Simplex Trading, LLC | 0.00% | Reduce -69.0% | 1,864 | $2K |
| PFS Partners, LLC | 0.00% | No change | 340 | $531 |
| Cypress Capital, LLC | 0.00% | New | 200 | $312 |
| Sachetta, LLC | 0.00% | New | 150 | $297 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -98.0% | 188 | $294 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 52 | $81 |
| Strategic Investment Solutions, Inc. | 0.00% | — | 8 | $16 |
| Morgan Stanley | 0.00% | Reduce -100.0% | 1 | $2 |
"% of holder's portfolio" is ATYR's weight in each manager's 13F, not the share of Atyr Pharma Inc. the manager owns.